CANCER DIAGNOSTICS BY REVOLUTIONARY METHOD
Our VOC technology enables, in its simplicity, a method to detect ovarian cancer through smell in a blood sample.
IN THE NEAR FUTURE
We are further developing our product and collecting clinical evidence to obtain regulatory approval in the European market.
ADVANCING CANCER DIAGNOSTICS
Our mission is to enable a paradigm shift in early diagnosis of ovarian cancer through unmatched performance regarding sensitivity and specificity.
OUR UNIQUE SOLUTION
VOC Diagnostics has developed a unique detection method by analyzing volatile organic compounds from blood plasma samples to detect ovarian cancer with higher accuracy than any other available method.
We welcome partnerships with academia to explore clinical applications across indications
We welcome interest from investors and are happy to provide more information on VOC Diagnostics’ plans for development and commercialization on request
VOC Diagnostics is looking to expand the team on all levels, feel free to contact us